Diana Bruen, RDN, and Dr. Weimbs gave a presentation titled "New Insights for Nutritional Interventions for Polycystic Kidney Disease" at the recent Spring Clinical Meetings SCM21 conference of the National Kidney Foundation.
Congratulations to the following undergraduate students who have all been awarded Undergraduate Research and Creative Activities (URCA) Grants to support independent research projects in the Weimbs lab. Each grant comes with $750 to support lab research. The grants are to support various research projects on polycystic kidney disease that are going on in the lab.
Congratulations to Julia Sergejeva, Claudia Do, Adriana Getman, Juliette Rebello, and Miles Ellman !
Giovannone AJ, Reales E, Bhattaram P, Nackeeran S, Monahan AB, Syed R, Weimbs T. The Habc domain of syntaxin 3 is a ubiquitin binding domain. Sci Rep. 2020;10(1):21350.
Dafinger C, Mandel AM, Braun A, Göbel H, Burgmaier K, Massella L, Mastrangelo A, Dötsch J, Benzing T, Weimbs T, Schermer B, Liebau MC. The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation. J Cell Mol Med. 2020 Oct 28. doi: 10.1111/jcmm.16014. Epub ahead of print. PMID: 33112055.
Dr. Weimbs was awarded a research grant from the Department of Defense (Peer Reviewed Medical Research Program, Investigator-Initiated Research Award). The title of the study is "Ketosis as a therapy for polycystic kidney disease".
to conduct a clinical trial titled: "KETO-ADPKD — A pilot trial of ketogenic dietary interventions in ADPKD". This pilot and feasibility trial will be conducted at the University Hospital in Cologne, Germany.
